New Treatment for Late-Stage Pancreatic Cancer

Monday, 09 Sep 2013 11:00 AM

 

Share:
A    A   |
   Email Us   |
   Print   |
   Forward Article  |
  Copy Shortlink
U.S. Food and Drug Administration approval for Abraxane (paclitaxel) has been expanded to include advanced pancreatic cancer, the agency said.

The agency previously approved the chemotherapy drug to treat cancers of the lung and breast.

Some 45,220 people are expected to be diagnosed with pancreatic cancer this year, and an estimated 38,460 will die from it.
 
Pancreatic cancer is the fourth-leading cause of cancer death. Surgery is the only way to permanently remove pancreatic cancer, but it's usually too late for surgery by the time most cases are identified.

Abraxane's safety and effectiveness in treating pancreatic cancer were evaluated in clinical trials involving 861 people. Those treated with Abraxane and another chemotherapy drug, gemcitabine, lived an average of 1.8 months longer than those treated with gemcitabine alone.
 
Common side effects of the drug combination included a drop in white blood cells and blood platelets, fatigue, nerve damage in the extremities, vomiting, diarrhea and fever.
Abraxane is marketed by Celgene, based in Summit, N.J.

© HealthDay

Share:
   Email Us   |
   Print   |
   Forward Article  |
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Once-a-Week Diabetes Drug

Tuesday, 15 Apr 2014 12:10 PM

The U.S. Food and Drug Administration approved GlaxoSmithKline Plc's Tanzeum injection for treating adults with type 2 d . . .

Grass Allergy Pill a First for US Sufferers

Wednesday, 02 Apr 2014 07:05 AM

France's Stallergenes has received U.S. regulatory approval to sell the first immunotherapy pill against grass allergies . . .

New Help for Hemophilia Patients

Saturday, 29 Mar 2014 10:07 AM

The Food and Drug Administration has approved the first hemophilia B treatment designed to decrease frequency of injecti . . .

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved